Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sernova Biotherapeutics Inc (TSV:SVA)

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Jun 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.550 (51)
Ask (Size) 1.610 (5)
Prev. Close 1.570
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted to the global Covax program following its approval by the WHO The approval could have limited... 
Via Benzinga
SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
From Sinovac Biotech Ltd.
Via Business Wire

Performance

More News

Read More
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F
From Sinovac Biotech Ltd.
Via Business Wire
Sinovac Amends Shareholder Rights Plan
From Sinovac Biotech Ltd.
Via Business Wire
HFCAA News: 128 Chinese Stocks the SEC Could Delist
Via InvestorPlace
New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report
Via Benzinga
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
Via Benzinga
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
Via Benzinga
SINOVAC Reports Unaudited First Half of 2021 Financial Results
From Sinovac Biotech Ltd.
Via Business Wire
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
From SINOVAC Biotech Ltd.
Via Business Wire
SINOVAC Beijing Settled Litigation of Its Business License and Seals
From SINOVAC Biotech Ltd.
Via Business Wire
Preliminary Results Show SINOVAC’s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population
From SINOVAC Biotech Ltd.
Via Business Wire
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
Via Benzinga
Exposures COVID-19
Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion
Via Talk Markets
New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant
From SINOVAC Biotech Ltd.
Via Business Wire
SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
From SINOVAC Biotech Ltd.
Via Business Wire
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Via Benzinga
Exposures COVID-19
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
Via Benzinga
Exposures COVID-19
SINOVAC Announces Positive Data on Booster Shots of CoronaVac®, Induces Strong Immune Response in Adult and Elderly Populations
From SINOVAC Biotech Ltd.
Via Business Wire
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
Via Benzinga
Exposures COVID-19
SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sIPV) to Support Global Polio Endgame Strategy
From SINOVAC Biotech Ltd.
Via Business Wire
Lancet Study Shows BioNTech COVID-19 Vaccine Generates 10X Higher Antibody Levels Compared to Sinovac Shot
Via Benzinga
Exposures COVID-19
SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX
From SINOVAC Biotech Ltd.
Via Business Wire
The Lancet Infectious Diseases Published Data from Sinovac’s Phase I/II Study, World’s First Published Study on Clinical Trial Results of a COVID-19 Vaccine in Healthy Children and Adolescents Aged 3 to 17 Years Old
From Sinovac Biotech Ltd.
Via Business Wire
World Health Organization Authorizes SINOVAC’s CoronaVac® for Emergency Use
From SINOVAC Biotech Ltd.
Via Business Wire

Frequently Asked Questions

Is Sernova Biotherapeutics Inc publicly traded?
Yes, Sernova Biotherapeutics Inc is publicly traded.
What exchange does Sernova Biotherapeutics Inc trade on?
Sernova Biotherapeutics Inc trades on the Toronto Venture Stock Exchange
What is the ticker symbol for Sernova Biotherapeutics Inc?
The ticker symbol for Sernova Biotherapeutics Inc is SVA on the Toronto Venture Stock Exchange
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.